NewCardio Company Top Insiders
| NWCI Stock | USD 0.0001 0.00 0.00% |
NewCardio employs about 10 people. The company is managed by 2 executives with a total tenure of roughly 24 years, averaging almost 12.0 years of service per executive, having 5.0 employees per reported executive. Assessment of NewCardio's management performance can provide insight into the firm performance.
NewCardio | Build AI portfolio with NewCardio Stock |
NewCardio Management Team Effectiveness
The company has return on total asset (ROA) of (2.2419) % which means that it has lost $2.2419 on every $100 spent on assets. This is way below average. NewCardio's management efficiency ratios could be used to measure how well NewCardio manages its routine affairs as well as how well it operates its assets and liabilities. The NewCardio's current Return On Capital Employed is estimated to increase to 11.66, while Return On Tangible Assets are projected to decrease to (4.96). As of now, NewCardio's Intangible Assets are increasing as compared to previous years.The current Net Loss is estimated to decrease to about (10.9 M)Some institutional investors establish a significant position in stocks such as NewCardio in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of NewCardio, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
NewCardio Workforce Comparison
NewCardio is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 1,744. NewCardio maintains roughly 10.0 in number of employees contributing less than 1% to equities under Health Care industry.
NewCardio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NewCardio insiders, such as employees or executives, is commonly permitted as long as it does not rely on NewCardio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, NewCardio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
NewCardio Notable Stakeholders
A NewCardio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as NewCardio often face trade-offs trying to please all of them. NewCardio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting NewCardio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jess MD | CEO Director | Profile | |
| Greg Sadowski | Chief Officer | Profile |
About NewCardio Management Performance
The success or failure of an entity such as NewCardio often depends on how effective the management is. NewCardio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of NewCardio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the NewCardio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.73) | (4.96) | |
| Return On Capital Employed | 11.10 | 11.66 | |
| Return On Assets | (4.63) | (4.87) | |
| Return On Equity | 4.18 | 2.57 |
NewCardio Workforce Analysis
Traditionally, organizations such as NewCardio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare NewCardio within its industry.NewCardio Manpower Efficiency
Return on NewCardio Manpower
| Revenue Per Employee | 25.7K | |
| Revenue Per Executive | 128.7K | |
| Net Loss Per Employee | 1.1M | |
| Net Loss Per Executive | 5.7M |
Complementary Tools for NewCardio Stock analysis
When running NewCardio's price analysis, check to measure NewCardio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewCardio is operating at the current time. Most of NewCardio's value examination focuses on studying past and present price action to predict the probability of NewCardio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewCardio's price. Additionally, you may evaluate how the addition of NewCardio to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| CEOs Directory Screen CEOs from public companies around the world |